查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1965386

數位乳房斷層合成設備市場－全球產業規模、佔有率、趨勢、機會、預測：按產品類型、最終用戶、地區和競爭對手分類，2021-2031年

Digital Breast Tomosynthesis Equipment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type, By End-User, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球數位乳房斷層合成設備市場預計將從 2025 年的 35.2 億美元成長到 2031 年的 63.1 億美元，複合年成長率為 10.22%。

作為診斷技術，數位乳房斷層合成技術能夠從不同角度拍攝多張X光片，並重建乳房組織的3D截面影像。市場成長的主要驅動力是乳癌發生率的不斷上升，以及臨床醫生對這種在緻密乳房組織病變檢測方面比傳統乳房X光攝影更具精準度的技術的強烈偏好。此外，各國政府強制推行定期篩檢政策，也持續推動全球醫療機構對這些先進診斷系統的需求。

市場概覽
預測期 2027-2031
市場規模：2025年 35.2億美元
市場規模：2031年 63.1億美元
複合年成長率：2026-2031年 10.22%
成長最快的細分市場 2D/3D聯合乳房X光攝影系統
最大的市場 北美洲

儘管存在這些積極跡象，但斷層合成設備高的購買和營運成本仍然是市場擴張的主要障礙。這限制了其在資源匱乏環境中的應用。即使疾病負擔日益加重，對先進早期檢測能力的需求也日益迫切，但這一經濟障礙依然存在。美國癌症協會估計，到2024年，美國女性將新增約310,720例浸潤性乳癌病例，凸顯了對便利有效的診斷解決方案的迫切需求，也印證了這項需求的嚴峻性。

市場促進因素

技術創新和人工智慧 (AI) 的整合正在透過提高診斷準確性和最佳化臨床工作流程，改變全球數位乳房斷層合成設備市場。將 AI 引入 3D乳房X光攝影系統，能夠有效應對解讀容積數據的複雜挑戰，降低假陽性率，並減輕放射科醫生的疲勞。利用深度學習演算法，可以更精準地辨識緻密組織中那些常被傳統方法忽略的細微惡性腫瘤。作為這項進展的佐證，iCAD 公司於 2024 年 11 月報告稱，其獲得 FDA 批准的 ProFound Detection 4.0 版軟體的受試者工作特徵曲線下面積(AUC) 提高了 6.3%，凸顯了現代 AI 增強型解決方案的顯著。

同時，全球乳癌發生率的上升是推動斷層合成設備廣泛應用的主要動力，也因此亟需建立更完善的全球篩檢體系。醫療機構正在加速向3D成像技術轉型，以應對不斷成長的患者群體，並透過早期檢測提高存活率。世界衛生組織（WHO）於2024年2月發布的數據顯示，乳癌是全球第二大常見癌症，2022年新增病例約230萬例。長期市場趨勢也印證了這日益加重的疾病負擔。美國癌症協會於2024年10月發布報告稱，2012年至2021年間，乳癌發生率年均成長1%，這一趨勢凸顯了對能夠精準應對日益成長的篩檢需求的先進診斷設備的持續需求。

市場挑戰

實施和維護數位乳房斷層合成系統所需的大量資本投入是限制市場成長的主要阻礙因素。許多醫療機構，特別是新興經濟體的區域醫院和醫療機構，難以負擔這些3D成像系統的費用，因為它們比標準乳房X光攝影設備更昂貴。這種價格差異迫使許多機構放棄投資新技術，轉而延長現有設備的使用壽命，從而有效地阻礙了價格敏感型市場對數位乳房斷層合成系統的廣泛應用。

影像服務報銷率持續下調，加劇了這項經濟挑戰，限制了用於升級資本設備的資金。據美國放射學會稱，2024年聯邦醫療保險（Medicare）醫生報銷表中的轉換係數同比下降了約1.69%。如此低的報銷水準限制了放射科診所收回斷層合成設備高昂的初始成本和營運成本的財務能力，直接阻礙了全球市場的預期擴張。

市場趨勢

該領域的一個顯著趨勢是採用針對高密度乳房組織的個人化篩檢通訊協定，這正在顯著影響籌資策略。這項轉變主要源自於新規的實施，新規強制要求告知乳房密度，迫使醫療機構優先選擇數位乳房斷層合成（DBT）而非傳統的2D乳房X光攝影來檢查纖維組織患者。與可能掩蓋病灶的標準檢查方式不同，斷層合成技術能夠提供滿足這些新的患者照護標準所需的深度解析度。例如，為了說明這項要求的重要性，《私人健康管理》雜誌在2024年10月針對美國食品藥物管理局（FDA）的新規指出，近一半40歲以上的女性患有高密度乳房組織，這凸顯了龐大的患者群體需要先進的3D成像技術來進行正確診斷。

同時，市場正經歷著向高性能3D斷層合成系統的強勁轉變。這主要是由於醫療機構以更有效率、高通量的技術取代老舊設備所致。隨著醫療機構升級到能夠產生合成2D影像和進行高速掃描的高階機架系統，製造商的資本投資銷售持續成長。即使在經濟壓力日益增大的情況下，這些系統仍然是產生收入資產的重點。這種強勁的硬體投資也體現在近期的企業獲利中。 2024年7月，Hologic公司公佈其乳房健康部門的營收年增6.9%，主要得益於機架銷售和業務收益的強勁成長。這些數據表明，醫療服務提供者正在持續投資最先進的系統，以保持其診斷標準的競爭力。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球數位乳房斷層合成設備市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 產品類型（2D/3D組合式乳房X光攝影系統、獨立式3D乳房X光攝影系統）
    • 依最終使用者（醫院、診斷中心和其他最終使用者）分類
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美數位乳房斷層合成設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲數位乳房斷層合成設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區數位乳房斷層合成設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲數位乳房斷層合成設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲數位乳房斷層合成設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球數位乳房斷層合成設備市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • PerkinElmer Inc.
  • Hologic, Inc
  • GE HealthCare Technologies Inc.
  • Fujifilm Holdings Corporation
  • Siemens Healthineers
  • General Medical Merate SpA
  • Varex Imaging Corporation
  • Trivitron Healthcare
  • Metaltronica Spa
  • Analogic Corporation

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 23908

The Global Digital Breast Tomosynthesis Equipment Market is projected to expand from USD 3.52 Billion in 2025 to USD 6.31 Billion by 2031, reflecting a compound annual growth rate of 10.22%. As a diagnostic modality, digital breast tomosynthesis functions by capturing multiple X-ray images from various angles to reconstruct three-dimensional cross-sectional views of breast tissue. The market's growth is largely driven by the increasing prevalence of breast cancer and a strong clinical preference for technologies that provide superior accuracy in detecting lesions within dense breast tissue compared to conventional mammography. Furthermore, the implementation of government initiatives mandating regular screening programs continues to strengthen the demand for these advanced diagnostic systems in healthcare facilities globally.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 3.52 Billion
Market Size 2031USD 6.31 Billion
CAGR 2026-203110.22%
Fastest Growing Segment2D/3D Combination Mammography Systems
Largest MarketNorth America

Despite these positive indicators, a significant hurdle to broader market growth remains the substantial acquisition and operational costs linked to tomosynthesis equipment, which restricts adoption in resource-limited environments. This financial obstacle persists even as the rising disease burden creates an urgent need for advanced early detection capabilities. Highlighting the severity of this demand, the American Cancer Society estimated that in 2024, approximately 310,720 new cases of invasive breast cancer would be diagnosed among women in the United States, underscoring the critical necessity for accessible and effective diagnostic solutions.

Market Driver

Technological innovations and the integration of artificial intelligence are transforming the Global Digital Breast Tomosynthesis Equipment Market by refining diagnostic precision and optimizing clinical workflows. The incorporation of AI into 3D mammography systems tackles the difficulty of interpreting complex volumetric data, thereby lowering false-positive rates and alleviating radiologist fatigue. By utilizing deep learning algorithms, these systems demonstrate improved proficiency in identifying subtle malignancies within dense tissue that might otherwise be overlooked by traditional methods. As evidence of this advancement, iCAD, Inc. reported in November 2024 that their FDA-cleared ProFound Detection Version 4.0 software achieved a 6.3% improvement in the area under the receiver operating characteristic curve (AUC), highlighting the measurable benefits of modern AI-enhanced solutions.

Simultaneously, the rising global incidence of breast cancer serves as a primary driver for the widespread adoption of tomosynthesis equipment, creating a need for more robust worldwide screening infrastructures. Healthcare providers are increasingly shifting toward 3D modalities to manage expanding patient volumes and secure better survival outcomes through earlier detection. According to the World Health Organization in February 2024, breast cancer was the second most common cancer globally, with roughly 2.3 million new cases diagnosed in 2022. This growing disease burden is further confirmed by long-term market trends; the American Cancer Society noted in October 2024 that breast cancer incidence rates rose by 1% annually from 2012 to 2021, a trajectory that reinforces the continued demand for advanced diagnostic equipment capable of handling higher screening loads with precision.

Market Challenge

The significant capital expenditure necessary to acquire and maintain digital breast tomosynthesis systems acts as a major constraint on market growth. Many healthcare providers, especially community hospitals and facilities in emerging economies, struggle to afford the premium costs of these three-dimensional imaging modalities compared to standard mammography units. This price gap compels many organizations to prolong the lifespan of legacy equipment instead of investing in newer technology, effectively halting widespread adoption in price-sensitive markets.

This economic challenge is further exacerbated by continuous downward pressure on reimbursement rates for imaging services, which restricts funds available for capital equipment upgrades. According to the American College of Radiology, the Medicare Physician Fee Schedule conversion factor decreased by approximately 1.69 percent in 2024 compared to the previous year. Such reductions in reimbursement levels limit the financial capacity of radiology practices to recoup the high acquisition and operational expenses associated with tomosynthesis equipment, thereby directly obstructing the projected expansion of the global market.

Market Trends

A defining trend in the sector is the adoption of personalized screening protocols for dense breast tissue, which is significantly shaping procurement strategies. This shift is largely driven by recently enforced regulations mandating breast density notification, compelling healthcare providers to prioritize Digital Breast Tomosynthesis (DBT) over traditional 2D mammography for patients with fibroglandular tissue. Unlike standard modalities where lesions may be hidden, tomosynthesis provides the depth resolution needed to meet these new patient-care standards. Highlighting the extent of this requirement, Private Health Management noted in October 2024 regarding a new FDA rule that nearly half of women over 40 possesses dense breast tissue, emphasizing the vast population now requiring these advanced 3D imaging capabilities for adequate diagnosis.

In parallel, the market is experiencing a strong shift toward high-performance 3D tomosynthesis systems as facilities replace aging installed bases with more efficient, high-throughput technology. Manufacturers are seeing sustained momentum in capital equipment sales as providers upgrade to premium gantries that offer synthesized 2D imaging and faster scan times, prioritizing these revenue-generating assets despite broader economic pressures. This resilience in hardware investment is reflected in recent corporate results; Hologic, Inc. reported in July 2024 that Breast Health revenue increased by 6.9% year-over-year, a rise primarily driven by robust gantry sales and service revenue. This data signals a continued commitment from healthcare providers to invest in state-of-the-art systems to uphold competitive diagnostic standards.

Key Market Players

  • PerkinElmer Inc.
  • Hologic, Inc
  • GE HealthCare Technologies Inc.
  • Fujifilm Holdings Corporation
  • Siemens Healthineers
  • General Medical Merate SpA
  • Varex Imaging Corporation
  • Trivitron Healthcare
  • Metaltronica Spa
  • Analogic Corporation

Report Scope

In this report, the Global Digital Breast Tomosynthesis Equipment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Digital Breast Tomosynthesis Equipment Market, By Product Type

  • 2D/3D Combination Mammography Systems
  • Standalone 3D Mammography Systems

Digital Breast Tomosynthesis Equipment Market, By End-User

  • Hospitals
  • Diagnostic Centers
  • Other End-Users

Digital Breast Tomosynthesis Equipment Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Digital Breast Tomosynthesis Equipment Market.

Available Customizations:

Global Digital Breast Tomosynthesis Equipment Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Digital Breast Tomosynthesis Equipment Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product Type (2D/3D Combination Mammography Systems, Standalone 3D Mammography Systems)
    • 5.2.2. By End-User (Hospitals, Diagnostic Centers, Other End-Users)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Digital Breast Tomosynthesis Equipment Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product Type
    • 6.2.2. By End-User
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Digital Breast Tomosynthesis Equipment Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product Type
        • 6.3.1.2.2. By End-User
    • 6.3.2. Canada Digital Breast Tomosynthesis Equipment Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product Type
        • 6.3.2.2.2. By End-User
    • 6.3.3. Mexico Digital Breast Tomosynthesis Equipment Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product Type
        • 6.3.3.2.2. By End-User

7. Europe Digital Breast Tomosynthesis Equipment Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product Type
    • 7.2.2. By End-User
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Digital Breast Tomosynthesis Equipment Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product Type
        • 7.3.1.2.2. By End-User
    • 7.3.2. France Digital Breast Tomosynthesis Equipment Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product Type
        • 7.3.2.2.2. By End-User
    • 7.3.3. United Kingdom Digital Breast Tomosynthesis Equipment Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product Type
        • 7.3.3.2.2. By End-User
    • 7.3.4. Italy Digital Breast Tomosynthesis Equipment Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product Type
        • 7.3.4.2.2. By End-User
    • 7.3.5. Spain Digital Breast Tomosynthesis Equipment Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product Type
        • 7.3.5.2.2. By End-User

8. Asia Pacific Digital Breast Tomosynthesis Equipment Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product Type
    • 8.2.2. By End-User
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Digital Breast Tomosynthesis Equipment Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product Type
        • 8.3.1.2.2. By End-User
    • 8.3.2. India Digital Breast Tomosynthesis Equipment Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product Type
        • 8.3.2.2.2. By End-User
    • 8.3.3. Japan Digital Breast Tomosynthesis Equipment Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product Type
        • 8.3.3.2.2. By End-User
    • 8.3.4. South Korea Digital Breast Tomosynthesis Equipment Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product Type
        • 8.3.4.2.2. By End-User
    • 8.3.5. Australia Digital Breast Tomosynthesis Equipment Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product Type
        • 8.3.5.2.2. By End-User

9. Middle East & Africa Digital Breast Tomosynthesis Equipment Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product Type
    • 9.2.2. By End-User
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Digital Breast Tomosynthesis Equipment Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product Type
        • 9.3.1.2.2. By End-User
    • 9.3.2. UAE Digital Breast Tomosynthesis Equipment Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product Type
        • 9.3.2.2.2. By End-User
    • 9.3.3. South Africa Digital Breast Tomosynthesis Equipment Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product Type
        • 9.3.3.2.2. By End-User

10. South America Digital Breast Tomosynthesis Equipment Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product Type
    • 10.2.2. By End-User
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Digital Breast Tomosynthesis Equipment Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product Type
        • 10.3.1.2.2. By End-User
    • 10.3.2. Colombia Digital Breast Tomosynthesis Equipment Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product Type
        • 10.3.2.2.2. By End-User
    • 10.3.3. Argentina Digital Breast Tomosynthesis Equipment Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product Type
        • 10.3.3.2.2. By End-User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Digital Breast Tomosynthesis Equipment Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. PerkinElmer Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Hologic, Inc
  • 15.3. GE HealthCare Technologies Inc.
  • 15.4. Fujifilm Holdings Corporation
  • 15.5. Siemens Healthineers
  • 15.6. General Medical Merate SpA
  • 15.7. Varex Imaging Corporation
  • 15.8. Trivitron Healthcare
  • 15.9. Metaltronica Spa
  • 15.10. Analogic Corporation

16. Strategic Recommendations

17. About Us & Disclaimer